206 related articles for article (PubMed ID: 36076924)
1. Targeting Melanin in Melanoma with Radionuclide Therapy.
Allen KJH; Malo ME; Jiao R; Dadachova E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076924
[TBL] [Abstract][Full Text] [Related]
2. Targeted Radionuclide Therapy of Melanoma.
Norain A; Dadachova E
Semin Nucl Med; 2016 May; 46(3):250-9. PubMed ID: 27067506
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma.
Malo ME; Allen KJH; Jiao R; Frank C; Rickles D; Dadachova E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218169
[TBL] [Abstract][Full Text] [Related]
4. Melanin as a potential target for radionuclide therapy of metastatic melanoma.
Dadachova E; Casadevall A
Future Oncol; 2005 Aug; 1(4):541-9. PubMed ID: 16556030
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
6. Renaissance of targeting molecules for melanoma.
Dadachova E; Casadevall A
Cancer Biother Radiopharm; 2006 Dec; 21(6):545-52. PubMed ID: 17257069
[TBL] [Abstract][Full Text] [Related]
7. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.
Howell RC; Revskaya E; Pazo V; Nosanchuk JD; Casadevall A; Dadachova E
Bioconjug Chem; 2007; 18(6):1739-48. PubMed ID: 17907769
[TBL] [Abstract][Full Text] [Related]
8. A Theranostic Approach to Imaging and Treating Melanoma with
Jiao R; Allen KJH; Malo ME; Yilmaz O; Wilson J; Nelson BJB; Wuest F; Dadachova E
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568672
[TBL] [Abstract][Full Text] [Related]
9. Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma.
Choi J; Beaino W; Fecek RJ; Fabian KPL; Laymon CM; Kurland BF; Storkus WJ; Anderson CJ
J Nucl Med; 2018 Dec; 59(12):1843-1849. PubMed ID: 29959213
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy.
Nosanchuk JD; Jeyakumar A; Ray A; Revskaya E; Jiang Z; Bryan RA; Allen KJH; Jiao R; Malo ME; Gómez BL; Morgenstern A; Bruchertseifer F; Rickles D; Thornton GB; Bowen A; Casadevall A; Dadachova E
Sci Rep; 2018 Apr; 8(1):5466. PubMed ID: 29615812
[TBL] [Abstract][Full Text] [Related]
11. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin.
Dadachova E; Nosanchuk JD; Shi L; Schweitzer AD; Frenkel A; Nosanchuk JS; Casadevall A
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14865-70. PubMed ID: 15469923
[TBL] [Abstract][Full Text] [Related]
12. Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical/clinical development and combination with other treatments.
Rouanet J; Quintana M; Auzeloux P; Cachin F; Degoul F
Pharmacol Ther; 2021 Aug; 224():107829. PubMed ID: 33662452
[TBL] [Abstract][Full Text] [Related]
13. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
[TBL] [Abstract][Full Text] [Related]
14. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice.
Dadachova E; Revskaya E; Sesay MA; Damania H; Boucher R; Sellers RS; Howell RC; Burns L; Thornton GB; Natarajan A; Mirick GR; DeNardo SJ; DeNardo GL; Casadevall A
Cancer Biol Ther; 2008 Jul; 7(7):1116-27. PubMed ID: 18535406
[TBL] [Abstract][Full Text] [Related]
16. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy.
Jandl T; Revskaya E; Jiang Z; Harris M; Dorokhova O; Tsukrov D; Casadevall A; Dadachova E
Nucl Med Biol; 2013 Feb; 40(2):177-81. PubMed ID: 23146306
[TBL] [Abstract][Full Text] [Related]
17. Peptide-targeted radionuclide therapy for melanoma.
Miao Y; Quinn TP
Crit Rev Oncol Hematol; 2008 Sep; 67(3):213-28. PubMed ID: 18387816
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model.
Jiao R; Allen KJH; Malo ME; Rickles D; Dadachova E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991626
[TBL] [Abstract][Full Text] [Related]
20. Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma.
Jandl T; Revskaya E; Jiang Z; Bryan RA; Casadevall A; Dadachova E
Immunotherapy; 2013 Apr; 5(4):357-64. PubMed ID: 23557419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
